Table 2.
Correlation of the Expression of FEZF1-AS1 in Colorectal Cancer (CRC) With Clinicopathologic Characteristics
| Feature | lncRNA FEZF1-AS1 | χ2 | p Value | |
|---|---|---|---|---|
| Low | High | |||
| Age | 0.413 | 0.520 | ||
| <60 | 20 | 17 | ||
| ≥60 | 25 | 28 | ||
| Gender | 1.169 | 0.280 | ||
| Male | 30 | 25 | ||
| Female | 15 | 20 | ||
| Tumor size (cm) | 2.915 | 0.138 | ||
| <5 | 17 | 24 | ||
| ≥5 | 28 | 21 | ||
| Pathological differentiation | 0.494 | 0.482 | ||
| Well and moderate | 42 | 39 | ||
| Poor | 3 | 6 | ||
| T stage | 5.789 | 0.016* | ||
| T1 + T2 | 22 | 11 | ||
| T3 + T4 | 23 | 34 | ||
| Tumor embolus | 1.216 | 0.270 | ||
| Positive | 6 | 10 | ||
| Negative | 39 | 35 | ||
| TNM stage | 7.647 | 0.006* | ||
| I + II | 26 | 13 | ||
| III + IV | 19 | 32 | ||
*
p < 0.05.